FDA Approves Label Update for BRUKINSA® (zanubrutinib) in Chronic Lymphocytic Leukemia (CLL)
U.S. label update includes superior progression-free survival results from the Phase 3 ALPINE head-to-head trial…
U.S. label update includes superior progression-free survival results from the Phase 3 ALPINE head-to-head trial…
BEIJING, CHINA - Media OutReach Newswire - 22 December 2023 - From the Adama Wind…
SHENZHEN, China--(BUSINESS WIRE)--VOOPOO is excited to announce the arrival of the VOOPOO DRAG X2, DRAG…
HONG KONG SAR - Media OutReach Newswire - 22 December 2023 - KPMG China recently…
HONG KONG SAR - Media OutReach Newswire - 22 December 2023 - The Centre on…
SINGAPORE - Media OutReach Newswire - 22 December 2023 - FBS, a global trading platform,…
TOKYO--(BUSINESS WIRE)--Cellusion Inc. (CEO: Shin Hatou, M.D. Ph.D., “Cellusionâ€), a deep tech start-up developing a…
Get the latest information and hear the comments from voice actors! The release in North…
Enterprises and governments worldwide rely on Trend to bridge the gap between security and compliance…
OSLO, Norway--(BUSINESS WIRE)--#AIVirtualProximitySensor--Elliptic Labs (OSE: ELABS), a global AI software company and the world leader…